Venn Life Sciences

Dublin-listed pharma services company Open Orphan has signed a new three-year contract with a German pharmaceutical company, which it said will guaran(...)

Dalkey-based Integumen is to raise £1.4 million (€1.66 million) through a share placing and subscription to provide working capital as it looks to boo(...)

Dublin-listed pharma services company Open Orphan said on Monday it has agreed to merge with UK-based Hvivo in a £30 million (€35.7m) tie-up that clas(...)

Open Orphan, the pharma services business which completed a reverse takeover into clinical trials group Venn Life Sciences earlier this year, made a €(...)

Pharma services business Open Orphan, formerly known as Venn Life Sciences, has resumed trading on the stock exchanges in Dublin and London following (...)

Dublin-listed drug clinical trials manager Venn Life Sciences, which is in the process of merging with dealmaker Cathal Friel’s pharma services busine(...)

Leading corporate figure Cathal Friel is behind the proposed reverse takeover of listed clinical trials group Venn Life Sciences by pharma services bu(...)

A Canadian speciality pharmaceutical company has appointed Dublin man Conor Walshe as general manager of its European subsidiary. Theratechnologies,(...)

Clinical trials group Venn Life Sciences has signed a strategic collaboration with Open Orphan DAC as it seeks to increase its focus on rare diseases (...)

Big Pharma in Ireland has an image problem. At least that’s how it sees it. “I think we are not seen as a trusted partner,” says Aidan Lynch, presid(...)